| Traditional Uses, Phytochemistry, and Pharmacology of Olea europaea (Olive) MA Hashmi, A Khan, M Hanif, U Farooq, S Perveen Evidence‐Based Complementary and Alternative Medicine 2015 (1), 541591, 2015 | 476 | 2015 |
| Development of anticancer agents: wizardry with osmium M Hanif, MV Babak, CG Hartinger Drug Discovery Today 19 (10), 1640-1648, 2014 | 216 | 2014 |
| Anticancer metallodrugs: where is the next cisplatin? M Hanif, CG Hartinger Future medicinal chemistry 10 (6), 615-617, 2018 | 179 | 2018 |
| Breaking the intracellular redox balance with diselenium nanoparticles for maximizing chemotherapy efficacy on patient-derived xenograft models D Wei, Y Yu, X Zhang, Y Wang, H Chen, Y Zhao, F Wang, G Rong, ... ACS nano 14 (12), 16984-16996, 2020 | 156 | 2020 |
| In vitro anticancer activity and biologically relevant metabolization of organometallic ruthenium complexes with carbohydrate‐based ligands I Berger, M Hanif, AA Nazarov, CG Hartinger, RO John, ML Kuznetsov, ... Chemistry–A European Journal 14 (29), 9046-9057, 2008 | 152 | 2008 |
| Novel metal (II) arene 2-pyridinecarbothioamides: a rationale to orally active organometallic anticancer agents SM Meier, M Hanif, Z Adhireksan, V Pichler, M Novak, E Jirkovsky, ... Chemical Science 4 (4), 1837-1846, 2013 | 151 | 2013 |
| Pyrone derivatives and metals: From natural products to metal-based drugs W Kandioller, A Kurzwernhart, M Hanif, SM Meier, H Henke, BK Keppler, ... Journal of Organometallic Chemistry 696 (5), 999-1010, 2011 | 138 | 2011 |
| Theoretical insight of polypyrrole ammonia gas sensor H Ullah, K Ayub, Z Ullah, M Hanif, R Nawaz, AHA Shah, S Bilal Synthetic metals 172, 14-20, 2013 | 130 | 2013 |
| Is the Reactivity of M(II)−Arene Complexes of 3-Hydroxy-2(1H)-pyridones to Biomolecules the Anticancer Activity Determining Parameter? M Hanif, H Henke, SM Meier, S Martic, M Labib, W Kandioller, ... Inorganic chemistry 49 (17), 7953-7963, 2010 | 123 | 2010 |
| Anticancer Ruthenium(η6-p-cymene) Complexes of Nonsteroidal Anti-inflammatory Drug Derivatives F Aman, M Hanif, WA Siddiqui, A Ashraf, LK Filak, J Reynisson, ... Organometallics 33 (19), 5546-5553, 2014 | 113 | 2014 |
| Osmium (II)–versus ruthenium (II)–arene carbohydrate-based anticancer compounds: similarities and differences M Hanif, AA Nazarov, CG Hartinger, W Kandioller, MA Jakupec, VB Arion, ... Dalton Transactions 39 (31), 7345-7352, 2010 | 111 | 2010 |
| Maleimide-functionalised organoruthenium anticancer agents and their binding to thiol-containing biomolecules M Hanif, AA Nazarov, A Legin, M Groessl, VB Arion, MA Jakupec, ... Chemical Communications 48 (10), 1475-1477, 2012 | 105 | 2012 |
| Understanding failure and improving treatment using HDAC inhibitors for prostate cancer Z Rana, S Diermeier, M Hanif, RJ Rosengren Biomedicines 8 (2), 22, 2020 | 94 | 2020 |
| Design concepts of half-sandwich organoruthenium anticancer agents based on bidentate bioactive ligands WDJ Tremlett, DM Goodman, TR Steel, S Kumar, A Wieczorek-Błauż, ... Coordination chemistry reviews 445, 213950, 2021 | 91 | 2021 |
| Half‐Sandwich Ruthenium (II) Biotin Conjugates as Biological Vectors to Cancer Cells MV Babak, D Plażuk, SM Meier, HJ Arabshahi, J Reynisson, B Rychlik, ... Chemistry–A European Journal 21 (13), 5110-5117, 2015 | 79 | 2015 |
| Monodentately-coordinated bioactive moieties in multimodal half-sandwich organoruthenium anticancer agents TR Steel, F Walsh, A Wieczorek-Błauż, M Hanif, CG Hartinger Coordination chemistry reviews 439, 213890, 2021 | 78 | 2021 |
| From hydrolytically labile to hydrolytically stable RuII–arene anticancer complexes with carbohydrate-derived co-ligands M Hanif, SM Meier, W Kandioller, A Bytzek, M Hejl, CG Hartinger, ... Journal of Inorganic Biochemistry 105 (2), 224-231, 2011 | 77 | 2011 |
| Metal complexes of benzimidazole derived sulfonamide: Synthesis, molecular structures and antimicrobial activity A Ashraf, WA Siddiqui, J Akbar, G Mustafa, H Krautscheid, N Ullah, ... Inorganica Chimica Acta 443, 179-185, 2016 | 76 | 2016 |
| Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl2 Complexes D Truong, MP Sullivan, KKH Tong, TR Steel, A Prause, JH Lovett, ... Inorganic chemistry 59 (5), 3281-3289, 2020 | 71 | 2020 |
| Rollover cyclometalated bipyridine platinum complexes as potent anticancer agents: impact of the ancillary ligands on the mode of action MV Babak, M Pfaffeneder-Kmen, SM Meier-Menches, MS Legina, ... Inorganic chemistry 57 (5), 2851-2864, 2018 | 68 | 2018 |